Showing results (1-10 of 79) with videos related to
Sort By:
Pageof 8
Current Drug Targets. CNS and Neurological Disorders|February 18, 2004
5-HT1 receptorsLaurence Lanfumey, Michel HamonNeural Plasticity|July 21, 2007
Hippocampal neurogenesis, depressive disorders, and antidepressant therapyEleni Paizanis, Michel Hamon, Laurence LanfumeyMedecine Sciences : M/S|December 8, 2004
[Alcohol dependence and polymorphisms of serotonin-related genes]Philip Gorwood, Laurence Lanfumey, Michel HamonPharmacology & Therapeutics|January 26, 2013
Biological rhythms and melatonin in mood disorders and their treatmentsLaurence Lanfumey, Raymond Mongeau, Michel HamonPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences|July 25, 2012
Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depressionRenaud Massart, Raymond Mongeau, Laurence LanfumeyNeuroscience and Biobehavioral Reviews|November 1, 2011
Drug withdrawal-induced depression: serotonergic and plasticity changes in animal modelsThibault Renoir, Terence Y Pang, Laurence LanfumeyProgress in Molecular Biology and Translational Science|August 4, 2018
Neuroepigenetics of Neurotrophin Signaling: Neurobiology of Anxiety and Affective DisordersMathilde Règue-Guyon, Laurence Lanfumey, Raymond MongeauCurrent Drug Targets|February 16, 2006
Microdialysis approach to study serotonin outflow in mice following selective serotonin reuptake inhibitors and substance P (neurokinin 1) receptor antagonist administration: a reviewBruno P Guiard, Laurence Lanfumey, Alain M GardierNeuropharmacology|April 24, 2012
Early exposure to ethanol differentially affects ethanol preference at adult age in two inbred mouse strainsJenny Molet, Elodie Bouaziz, Michel Hamon, et al.Pageof 8